Division of Transplantation, Department of Surgery, University of California San Diego, La Jolla, CA, USA.
Clin Transplant. 2021 Jul;35(7):e14338. doi: 10.1111/ctr.14338. Epub 2021 May 18.
Growing research supports an increased survival benefit of combined heart and kidney transplantation in patients with both heart and renal failure. As a result, the frequency of these combined transplants continues to increase. Despite this trend, little has been done to quantify the impact of chronic illness in this population. We identified adult recipients of combined heart-kidney transplant from the Scientific Registry of Transplant Recipients (SRTR) database between 2005 and 2018. We focused on renal disease secondary to diabetes and duration of dialysis as markers of chronic illness. The primary outcome was post-transplant mortality. Our final multivariable Cox proportional hazard model found that diabetes-associated renal disease (HR 1.57, 95% CI 1.14-2.15, p = .01) and dialysis duration (HR 1.08, 95% CI 1.01-1.15, p = .02) were significant predictors of post-transplant mortality. Given the significant impact of dialysis duration and renal disease secondary to diabetes mellitus, these chronically ill patients should be closely examined for conditions such as peripheral vascular disease and frailty, which have been shown to affect mortality in heart transplant recipients and are prevalent in the chronic dialysis population.
越来越多的研究支持在同时患有心力衰竭和肾衰竭的患者中,联合心脏和肾脏移植具有更高的生存获益。因此,这些联合移植的频率继续增加。尽管有这种趋势,但在这个人群中,很少有人对慢性疾病的影响进行量化。我们从 2005 年至 2018 年的 Scientific Registry of Transplant Recipients(SRTR)数据库中确定了接受联合心脏-肾脏移植的成年受者。我们将糖尿病引起的肾脏疾病和透析持续时间作为慢性疾病的标志物来关注。主要结局是移植后的死亡率。我们最终的多变量 Cox 比例风险模型发现,糖尿病相关的肾脏疾病(HR 1.57,95%CI 1.14-2.15,p=0.01)和透析持续时间(HR 1.08,95%CI 1.01-1.15,p=0.02)是移植后死亡率的显著预测因素。鉴于透析持续时间和糖尿病引起的肾脏疾病的显著影响,这些患有慢性疾病的患者应仔细检查外周血管疾病和虚弱等情况,这些情况已被证明会影响心脏移植受者的死亡率,并且在慢性透析人群中很常见。